News

FDA Issues Highest Risk Warning For Cucumber Recall
Fuentes Farms LLC announced a voluntary recall of 71 boxes of fresh cucumbers on June 13 due to potential salmonella ...
Muffin recall update as FDA warns of potential metal parts in products
Products were distributed in New York, Pennsylvania, Massachusetts, New Jersey, Maryland, Virginia, Washington, D.C., North ...
FDA issues most serious risk warning for cheese recall
Face Rock Creamery issued a recall for its Vampire Slayer Garlic Cheddar Curds over possible Listeria monocytogenes ...
FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
MedPage Today on MSN12h
HHS Looks for DEI Whistleblowers; FDA Inspectors 'Reeling'; Sewage Health Crisis?
HHS sent an email to staff members that included a "whistle-blower questionnaire," and asked them to report cases of ...
Medical device company receives FDA approval for Parkinson’s treatment
The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.
Medical groups urge Kennedy, FDA to reexamine broad approval of abortion drugs
Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...
STAT2d
Inside the staff exodus and tanking morale that threaten Makary’s FDA
The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s work, current ...
CURE14h
FDA Approves Stoboclo and Osenvelt as Biosimilars Across Some Cancers
Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...
Fierce Pharma18h
Eli Lilly's Kisunla wins FDA nod for new dosing with fewer side effects in Alzheimer's
The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...
Healio15h
FDA approves garadacimab-gxii as prophylaxis for hereditary angioedema
The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, ...
Targeted Oncology13h
FDA Draft Guidance Illuminates MDS Drug Development Pathways
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...